FeesSafety
Pluang+

Suja Life targets $43B natural beverage market with strong growth and projected $360M revenue by 2026

Analyst Insights
09 Nov 2026, 14:30 WIB
Seeking Alpha
View Source
Bullish
Suja Life targets $43B natural beverage market with strong growth and projected $360M revenue by 2026

Suja Life is positioned as a modern beverage platform focusing on the fast-growing natural healthy beverages market. Its core brands are driving strong revenue and profit growth, while emerging brands are reducing losses and gaining market traction. Management forecasts revenue between $360 million and $369 million and EBITDA of $70 million to $72 million by 2026, supporting an attractive valuation. The company is rated a soft 'buy' due to its growth potential, improving fundamentals, and strong position in a $43 billion segment.

Suja Life's rapid growth and core brands provide context for this market snapshot. For readers following Consumer Staples, here is Pluang's market data as of Nov 09, 2026 18:12 WIB: out of 63 priced US stocks, 43 rose and 7 fell today. Notable movers include COCO at USD 64.54 with a 3.35% increase and a typical hold time of 13 days, OTLY at USD 8.06 up 2.54% with an 18-day hold, and SJM at USD 133.10 rising 1.95% with a 75-day hold. The most notable figure is COCO's 3.35% gain.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App